TILT Biotherapeutics

Advanced solid tumors are currently incurable and limited treatment options are available.

There are 8 million people dying from cancer each year and the incidence is growing.

TILT Biotherapeutics is developing a new treatment with curative potential for advanced cancer with oncolytic immunotherapy.